Escalier Biosciences
Edward Van Wezel is the current Director at Escalier Biosciences. Prior to this, they were with dualyx, Confo Therapeutics, AZAFAROS B.V., and Scenic Biotech. Edward has also been with Escalier Biosciences in the past. BGV (BioGeneration Ventures) is also included in their previous work history.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Escalier Biosciences
Escalier Biosciences is developing both topical and oral RORγt inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would benefit from a safe and effective topical RORγt therapeutic to the more moderate-to-severe patients that would benefit from a safe and effective oral RORγt drug in lieu of injectable biologic therapies targeting IL-17 and IL-23.